Literature DB >> 15303449

Potentially inappropriate drug prescribing among first-visit elderly outpatients in Taiwan.

Chia-Ming Chang1, Pheng-Ying Yeh Liu, Yea-Huei Kao Yang, Yi-Ching Yang, Chun-Feng Wu, Feng-Hwa Lu.   

Abstract

STUDY
OBJECTIVE: To determine the prevalence and risk factors of potentially inappropriate drug prescribing among first-visit elderly outpatients.
DESIGN: Cross-sectional survey.
SETTING: An urban tertiary care and academic medical center in southern Taiwan. PATIENTS: Eight hundred eighty-two patients aged 65 years or older who were prescribed drugs at their first visit to either the medical center's outpatient internal medicine clinic or family medicine clinic between March 1, 2001, and July 31, 2001.
MEASUREMENTS AND MAIN RESULTS: Potentially inappropriate drug prescribing was assessed according to updated Beers criteria. Ninety-seven potentially inappropriate drugs were identified in 93 (10.5%) patients. The most common classes were sedative-hypnotics (18.6%) and muscle relaxants (17.5%). Twenty (20.6%) of these inappropriate drugs had a high severity potential according to the Beers criteria. Patients prescribed potentially inappropriate drugs were more likely to be prescribed several drugs versus those who were not prescribed potentially inappropriate drugs (4.0+/-1.9 vs 2.8+/-1.4, p<0.001). Multiple logistic regression analysis revealed an interaction between age and the number of prescribed drugs on the risk of having potentially inappropriate drugs prescribed. In patients who were prescribed four agents or less, the risk was not associated with increasing age; in those who were prescribed five drugs or more, the risk was positively associated with increasing age.
CONCLUSION: Potentially inappropriate drug prescribing among first-visit elderly outpatients was relatively low. Increasing patient age combined with increased number of drugs prescribed was associated with increased risk of having potentially inappropriate drugs prescribed.

Entities:  

Mesh:

Year:  2004        PMID: 15303449     DOI: 10.1592/phco.24.9.848.36095

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  7 in total

Review 1.  Polypharmacy in older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Arti Hurria
Journal:  Oncologist       Date:  2010-04-24

2.  Prevalence of potentially inappropriate medication use in elderly patients: comparison between general medical and geriatric wards.

Authors:  Sabin S Egger; Andrea Bachmann; Nathalie Hubmann; Raymond G Schlienger; Stephan Krähenbühl
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Inappropriate Medication Use Among Underserved Elderly African Americans.

Authors:  Mohsen Bazargan; Hamed Yazdanshenas; Shelley Han; Gail Orum
Journal:  J Aging Health       Date:  2015-06-30

Review 4.  Evaluation of the heterogeneity of studies estimating the association between risk factors and the use of potentially inappropriate drug therapy for the elderly: a systematic review with meta-analysis.

Authors:  Ana Patrícia A L Santos; Daniel Tenório da Silva; Genival Araujo dos Santos Júnior; Carina Carvalho Silvestre; Marco Antônio Prado Nunes; Divaldo Pereira Lyra; Angelo Roberto Antoniolli
Journal:  Eur J Clin Pharmacol       Date:  2015-06-26       Impact factor: 2.953

5.  Association of potentially inappropriate medication use with adverse outcomes in ambulatory elderly patients with chronic diseases: experience in a Taiwanese medical setting.

Authors:  Hsi-Yen Lin; Chi-Chow Liao; Shou-Hsia Cheng; Pa-Chun Wang; Ya-Seng Hsueh
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

6.  The use of START/STOPP criteria for elderly patients in primary care.

Authors:  Muhteşem Erol Yayla; Uğur Bilge; Elif Binen; Ahmet Keskin
Journal:  ScientificWorldJournal       Date:  2013-06-12

7.  Prevalence of inappropriate medication using Beers criteria in Japanese long-term care facilities.

Authors:  Satoko Niwata; Yukari Yamada; Naoki Ikegami
Journal:  BMC Geriatr       Date:  2006-01-11       Impact factor: 3.921

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.